FIELD: medicine, pharmaceutics.
SUBSTANCE: object of the present invention is preparing a glucokinase activator effective as a pharmaceutical agent, such as an agent for preventing or treating diabetes, obesity and similar. The present invention presents the glucokinase activator containing a compound presented by formula 
:
wherein R1 represents hydrogen atom or halogen atom; R2 represents a group presented by formula 
or 
wherein each symbol is such as specified in the description, or its pharmaceutically acceptable salt.
EFFECT: developing the agent for preventing or treating diabetes, obesity.
16 cl, 536 ex, 1 tbl, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLIC COMPOUND | 2019 |
|
RU2786587C2 |
| NOVEL INDOLE DERIVATIVES HAVING IκB KINASE β INHIBITING ACTIVITY | 2008 |
|
RU2470918C2 |
| PYRAZINE DERIVATIVES, USEFUL AS ADENOSINE RECEPTOR ANTAGONISTS | 2006 |
|
RU2417994C2 |
| PYRAZOLE[1,5-a]PYRIMIDINE DERIVATIVE | 2006 |
|
RU2390523C2 |
| USING EP4 RECEPTOR ANTAGONISTS IN TREATING IL-23-MEDIATED DISEASES | 2011 |
|
RU2571816C2 |
| PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARING AND USING | 2006 |
|
RU2303597C1 |
| METHOD FOR PRODUCING FLUORINATED ORGANIC COMPOUNDS | 2019 |
|
RU2764719C1 |
| PREVENTIVE OR THERAPEUTIC REMEDY FOR PHOTODERMATOSIS | 2021 |
|
RU2812785C1 |
| 3,4-SUBSTITUTED 1H-PIRAZOLE COMPOUNDS AND THEIR APPLICATION AS CYCLIN-DEPENDANT KINASES (CDK) AND MODULATORS OF GLYCOGEN SYNTHASE KINASE-3 (GSK-3) | 2004 |
|
RU2408585C2 |
| HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2559896C2 |
